Literature DB >> 20104670

Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells.

Maurice M Garcia1, Thomas M Fandel, Guiting Lin, Alan W Shindel, Lia Banie, Ching-Shwun Lin, Tom F Lue.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is a major complication of type 2 diabetes, and many diabetic men with ED are refractory to common ED therapies. AIM: To determine whether autologous adipose tissue-derived stem cells (ADSCs) injected into the penis of impotent type 2 diabetic rats improve erectile function. MAIN OUTCOME MEASURES: Blood glucose levels, intracavernous pressure (ICP) increase upon cavernous nerve (CN) electrostimulation, and immunohistochemistry.
METHODS: Twenty-two male Zucker diabetic fatty (ZDF) rats were used. At 22 weeks of age, all the animals underwent unilateral CN electrostimulation and ICP measurement to confirm impotence. Paragonadal adipose tissue was harvested to procure ADSCs. The impotent animals were randomized to ADSC treatment and sham control groups. At 23 weeks of age, the treatment group animals underwent a penile injection of 1 million ADSCs; the control group animals received vehicle only. Erectile function studies were repeated at 26 weeks of age, followed by tissue harvest.
RESULTS: The rats developed diabetes within the first 10 weeks of age. At 22 weeks of age, 20 out of the 22 rats presented with ED. The post-treatment ICP increase during CN stimulation and ICP increase/mean arterial pressure were significantly higher in the treatment group compared with controls. Three weeks after injection into the corpus cavernosum, only a small number of BrdU-labeled ADSCs was detectable within corporal tissue of the treatment group. There was a significant increase in neuronal nitric oxide synthase (nNOS) in the penile dorsal nerve and in the number of endothelial cells in the corpora cavernosa of the rats in the treatment group.
CONCLUSION: Autologous ADSCs injected into the penis were effective to improve erectile function and to alter the microarchitecture of the corpus cavernosum. Since the number of ADSCs retained in the corpus cavernosum is very small, we postulate that their paracrine function, not trans-differentiation to smooth muscle or endothelial cells, is responsible for the improvement in penile function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20104670      PMCID: PMC2904063          DOI: 10.1111/j.1743-6109.2009.01541.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  29 in total

Review 1.  Adipocytokines - novel link between inflammation and vascular function?

Authors:  T J Guzik; D Mangalat; R Korbut
Journal:  J Physiol Pharmacol       Date:  2006-12       Impact factor: 3.011

Review 2.  Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!

Authors:  Ferdinando Mannello; Gaetana A Tonti
Journal:  Stem Cells       Date:  2007-03-29       Impact factor: 6.277

3.  Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

Authors:  Nelly Pitteloud; Megan Hardin; Andrew A Dwyer; Elena Valassi; Maria Yialamas; Dariush Elahi; Frances J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

4.  Defining stem and progenitor cells within adipose tissue.

Authors:  Guiting Lin; Maurice Garcia; Hongxiu Ning; Lia Banie; Ying-Lu Guo; Tom F Lue; Ching-Shwun Lin
Journal:  Stem Cells Dev       Date:  2008-12       Impact factor: 3.272

Review 5.  Evaluation and treatment of erectile dysfunction in men with diabetes mellitus.

Authors:  Jayant Dey; Mark Devin Shepherd
Journal:  Mayo Clin Proc       Date:  2002-03       Impact factor: 7.616

6.  Cause-specific excess deaths associated with underweight, overweight, and obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

Review 7.  Vasculogenic erectile dysfunction: newer therapeutic strategies.

Authors:  Mike B Siroky; Kazem M Azadzoi
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

8.  Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells.

Authors:  Ivana Rosová; Mo Dao; Ben Capoccia; Daniel Link; Jan A Nolta
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

9.  Comparison of the labeling efficiency of BrdU, DiI and FISH labeling techniques in bone marrow stromal cells.

Authors:  Na Li; Hui Yang; Lingling Lu; Chunli Duan; Chunli Zhao; Huanying Zhao
Journal:  Brain Res       Date:  2007-10-18       Impact factor: 3.252

10.  Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells.

Authors:  Gino Rigotti; Alessandra Marchi; Mirco Galiè; Guido Baroni; Donatella Benati; Mauro Krampera; Annalisa Pasini; Andrea Sbarbati
Journal:  Plast Reconstr Surg       Date:  2007-04-15       Impact factor: 4.730

View more
  45 in total

Review 1.  Stem cells: novel players in the treatment of erectile dysfunction.

Authors:  Haiyang Zhang; Maarten Albersen; Xunbo Jin; Guiting Lin
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

Review 2.  Adipose Tissue-Derived Stem Cells for the Treatment of Erectile Dysfunction.

Authors:  Ahmet Gokce; Taylor C Peak; Asim B Abdel-Mageed; Wayne J Hellstrom
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

Review 3.  Mesenchymal stem cell-based gene therapy for erectile dysfunction.

Authors:  J H Kim; H J Lee; Y S Song
Journal:  Int J Impot Res       Date:  2016-02-18       Impact factor: 2.896

4.  Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model.

Authors:  Haiyang Zhang; Xuefeng Qiu; Alan W Shindel; Hongxiu Ning; Ludovic Ferretti; Xunbo Jin; Guiting Lin; Ching-Shwun Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2011-10-18       Impact factor: 3.272

5.  Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties.

Authors:  Haiyang Zhang; Hongxiu Ning; Lia Banie; Guifang Wang; Guiting Lin; Tom F Lue; Ching-Shwun Lin
Journal:  Biochem Biophys Res Commun       Date:  2010-10-27       Impact factor: 3.575

6.  Isolation and passage of muscle-derived stem cells from the rat penile corpora cavernosa and induction of differentiation into smooth muscle cells.

Authors:  Li-Jun Xu; Bo-Xin Xue; Dong Chen; Jie Gao; Dong-Rong Yang; Chuan-Yang Sun; Yong Cui; Yu-Xi Shan
Journal:  Cytotechnology       Date:  2013-11-19       Impact factor: 2.058

7.  Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction.

Authors:  Maarten Albersen; Guiting Lin; Thomas M Fandel; Haiyang Zhang; Xuefeng Qiu; Ching-Shwun Lin; Tom F Lue
Journal:  Urology       Date:  2011-05-31       Impact factor: 2.649

8.  Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury.

Authors:  Thomas M Fandel; Maarten Albersen; Guiting Lin; Xuefeng Qiu; Hongxiu Ning; Lia Banie; Tom F Lue; Ching-Shwun Lin
Journal:  Eur Urol       Date:  2011-08-04       Impact factor: 20.096

9.  Advances in stem cell therapy for the lower urinary tract.

Authors:  Ching-Shwun Lin
Journal:  World J Stem Cells       Date:  2010-02-26       Impact factor: 5.326

Review 10.  The potential of cell-based therapy for diabetes and diabetes-related vascular complications.

Authors:  Aaron Liew; Timothy O'Brien
Journal:  Curr Diab Rep       Date:  2014-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.